Nifty
:
23985.35
Sensex
:
76765.92
-10.60 (-0.04%)
-69.86 (-0.09%)
Nifty
Sensex
:
:
23985.35
76765.92
-10.60 (-0.04%)
-69.86 (-0.09%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :
63/99

BSE: 532300 | NSE: WOCKPHARMA

NSE BSE
1890.10
28-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1859.9
  •  1898
  •  1843.7
  •  1865.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  361389
  •  677372108.4
  •  2422.3
  •  1086.7

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 30,659.83
  • 143.94
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 32,534.83
  • N/A
  • 6.22

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.08%
  • 2.81%
  • 27.31%
  • FII
  • DII
  • Others
  • 7.23%
  • 7.02%
  • 6.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.73
  • 0.87
  • 6.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 47.55
  • 16.00
  • 74.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.74
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.41
  • 2.93
  • 4.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 48.78
  • 44.73
  • 60.08

Earnings Forecasts:

(Updated: 25-07-2026)
Description
2026
2027
2028
2029
Adj EPS
52
15
-
-
P/E Ratio
36.35
126.01
-
-
Revenue
-
-
-
-
EBITDA
-
-
-
-
Net Income
-
-
-
-
ROA
-
-
-
-
P/B Ratio
-
-
-
-
ROE
-
-
-
-
FCFF
-
-
-
-
FCFF Yield
-
-
-
-
Net Debt
-
-
-
-
BVPS
-
-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
965.00
743.00
29.88%
888.00
721.00
23.16%
782.00
809.00
-3.34%
738.00
739.00
-0.14%
Expenses
740.00
679.00
8.98%
711.00
593.00
19.90%
604.00
699.00
-13.59%
666.00
648.00
2.78%
EBITDA
225.00
64.00
251.56%
177.00
128.00
38.28%
178.00
110.00
61.82%
72.00
91.00
-20.88%
EBIDTM
23.32%
8.61%
19.93%
17.75%
22.76%
13.60%
9.76%
12.31%
Other Income
45.00
15.00
200.00%
25.00
8.00
212.50%
21.00
9.00
133.33%
20.00
30.00
-33.33%
Interest
50.00
48.00
4.17%
60.00
60.00
0.00%
55.00
73.00
-24.66%
48.00
73.00
-34.25%
Depreciation
53.00
53.00
0.00%
65.00
55.00
18.18%
53.00
55.00
-3.64%
56.00
54.00
3.70%
PBT
189.00
-22.00
-
67.00
21.00
219.05%
91.00
-9.00
-
-109.00
-6.00
-
Tax
25.00
23.00
8.70%
6.00
1.00
500.00%
9.00
7.00
28.57%
-1.00
10.00
-
PAT
164.00
-45.00
-
61.00
20.00
205.00%
82.00
-16.00
-
-108.00
-16.00
-
PATM
16.99%
-6.06%
6.87%
2.77%
10.49%
-1.98%
-14.63%
-2.17%
EPS
10.25
-1.54
-
3.64
0.86
323.26%
4.81
-1.43
-
-5.56
-0.91
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
3,373.00
3,012.00
2,798.00
2,651.00
3,230.00
2,708.00
2,843.99
3,565.84
3,936.90
4,014.61
Net Sales Growth
-
11.99%
7.65%
5.55%
-17.93%
19.28%
-4.78%
-20.24%
-9.43%
-1.94%
 
Cost Of Goods Sold
-
1,132.00
1,132.00
1,165.00
1,111.00
1,267.00
1,135.00
1,203.45
1,636.31
1,797.53
1,662.07
Gross Profit
-
2,241.00
1,880.00
1,633.00
1,540.00
1,963.00
1,573.00
1,640.54
1,929.53
2,139.37
2,352.54
GP Margin
-
66.44%
62.42%
58.36%
58.09%
60.77%
58.09%
57.68%
54.11%
54.34%
58.60%
Total Expenditure
-
2,747.00
2,619.00
2,759.00
2,550.00
2,932.00
2,771.00
2,746.23
3,604.32
3,992.33
4,001.81
Power & Fuel Cost
-
120.00
113.00
107.00
103.00
98.00
82.00
85.41
93.30
77.80
110.10
% Of Sales
-
3.56%
3.75%
3.82%
3.89%
3.03%
3.03%
3.00%
2.62%
1.98%
2.74%
Employee Cost
-
725.00
651.00
629.00
637.00
749.00
763.00
743.33
800.38
937.06
966.51
% Of Sales
-
21.49%
21.61%
22.48%
24.03%
23.19%
28.18%
26.14%
22.45%
23.80%
24.07%
Manufacturing Exp.
-
204.00
171.00
142.00
126.00
169.00
145.00
120.90
153.76
135.27
179.40
% Of Sales
-
6.05%
5.68%
5.08%
4.75%
5.23%
5.35%
4.25%
4.31%
3.44%
4.47%
General & Admin Exp.
-
218.00
196.00
190.00
192.00
224.00
251.00
186.55
380.13
476.66
504.43
% Of Sales
-
6.46%
6.51%
6.79%
7.24%
6.93%
9.27%
6.56%
10.66%
12.11%
12.56%
Selling & Distn. Exp.
-
154.00
137.00
125.00
134.00
180.00
132.00
141.18
176.22
208.89
205.30
% Of Sales
-
4.57%
4.55%
4.47%
5.05%
5.57%
4.87%
4.96%
4.94%
5.31%
5.11%
Miscellaneous Exp.
-
194.00
219.00
401.00
247.00
245.00
263.00
265.41
364.22
359.12
205.30
% Of Sales
-
5.75%
7.27%
14.33%
9.32%
7.59%
9.71%
9.33%
10.21%
9.12%
9.32%
EBITDA
-
626.00
393.00
39.00
101.00
298.00
-63.00
97.76
-38.48
-55.43
12.80
EBITDA Margin
-
18.56%
13.05%
1.39%
3.81%
9.23%
-2.33%
3.44%
-1.08%
-1.41%
0.32%
Other Income
-
137.00
62.00
83.00
122.00
20.00
132.00
60.08
21.02
177.49
114.25
Interest
-
213.00
254.00
305.00
302.00
299.00
249.00
275.74
265.14
255.49
225.27
Depreciation
-
227.00
217.00
223.00
251.00
247.00
246.00
224.14
163.95
149.53
148.93
PBT
-
323.00
-16.00
-406.00
-330.00
-228.00
-426.00
-342.04
-446.55
-282.96
-247.15
Tax
-
39.00
41.00
52.00
-3.00
-132.00
-271.00
-204.09
-134.76
25.70
-21.11
Tax Rate
-
16.39%
-256.25%
-12.38%
0.48%
32.12%
47.71%
59.67%
30.18%
-4.01%
8.54%
PAT
-
213.00
-47.00
-463.00
-559.00
-244.00
-299.00
-163.78
-289.66
-608.30
-195.72
PAT before Minority Interest
-
199.00
-57.00
-472.00
-621.00
-279.00
-297.00
-137.95
-311.79
-666.85
-226.04
Minority Interest
-
14.00
10.00
9.00
62.00
35.00
-2.00
-25.83
22.13
58.55
30.32
PAT Margin
-
6.31%
-1.56%
-16.55%
-21.09%
-7.55%
-11.04%
-5.76%
-8.12%
-15.45%
-4.88%
PAT Growth
-
-
-
-
-
-
-
-
-
-
 
EPS
-
13.11
-2.89
-28.49
-34.40
-15.02
-18.40
-10.08
-17.83
-37.43
-12.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
4,940.00
4,353.00
3,359.00
3,354.00
3,849.00
3,376.00
2,671.67
2,674.80
2,852.15
3,336.71
Share Capital
81.00
81.00
77.00
72.00
72.00
55.00
55.37
55.34
55.32
55.27
Total Reserves
4,846.00
4,261.00
3,269.00
3,266.00
3,759.00
3,293.00
2,586.33
2,587.19
2,760.11
3,244.43
Non-Current Liabilities
1,235.00
887.00
617.00
-22.00
261.00
496.00
1,194.85
1,702.75
2,088.89
3,151.38
Secured Loans
769.00
274.00
0.00
222.00
260.00
500.00
1,237.44
1,653.25
2,167.84
2,887.11
Unsecured Loans
749.00
937.00
891.00
2.00
95.00
3.00
3.46
238.22
5.27
303.16
Long Term Provisions
40.00
29.00
28.00
26.00
32.00
84.00
45.60
53.48
64.89
94.23
Current Liabilities
1,622.00
2,042.00
2,791.00
3,435.00
3,207.00
3,121.00
3,497.18
2,863.66
2,691.71
1,978.81
Trade Payables
563.00
592.00
766.00
867.00
921.00
696.00
895.27
840.24
601.78
533.81
Other Current Liabilities
581.00
886.00
1,144.00
1,172.00
1,197.00
1,230.00
1,568.44
1,353.09
1,548.13
690.13
Short Term Borrowings
438.00
496.00
832.00
1,330.00
1,034.00
1,066.00
903.86
561.71
437.09
662.80
Short Term Provisions
40.00
68.00
49.00
66.00
55.00
129.00
129.61
108.62
104.71
92.07
Total Liabilities
8,138.00
7,586.00
7,070.00
7,075.00
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
Net Block
2,791.00
2,736.00
2,881.00
3,042.00
3,462.00
3,343.00
3,502.29
3,057.93
2,887.96
2,772.55
Gross Block
6,164.00
5,814.00
5,721.00
5,696.00
6,019.00
5,656.00
6,703.28
6,112.89
5,772.29
5,456.40
Accumulated Depreciation
3,373.00
3,078.00
2,840.00
2,654.00
2,557.00
2,313.00
3,200.99
3,054.96
2,884.33
2,683.85
Non Current Assets
5,441.00
5,017.00
4,886.00
4,867.00
5,081.00
4,951.00
5,319.66
4,756.39
4,598.88
4,313.57
Capital Work in Progress
2,379.00
2,033.00
1,722.00
1,539.00
1,342.00
1,379.00
1,584.53
1,445.48
1,432.57
1,243.95
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.45
0.45
0.45
0.45
Long Term Loans & Adv.
251.00
246.00
266.00
269.00
259.00
228.00
230.63
251.13
274.93
295.15
Other Non Current Assets
20.00
2.00
17.00
17.00
18.00
1.00
1.76
1.40
2.97
1.47
Current Assets
2,606.00
2,465.00
2,073.00
1,914.00
2,445.00
2,281.00
2,400.54
2,814.65
3,379.60
4,535.27
Current Investments
412.00
422.00
0.00
0.00
0.00
0.00
0.00
0.00
213.25
562.27
Inventories
887.00
725.00
640.00
658.00
769.00
799.00
716.20
819.36
855.71
1,107.95
Sundry Debtors
588.00
661.00
618.00
797.00
918.00
918.00
1,242.69
1,273.90
962.45
1,034.45
Cash & Bank
250.00
191.00
529.00
124.00
406.00
292.00
268.46
448.65
1,082.25
1,603.61
Other Current Assets
469.00
4.00
0.00
0.00
352.00
272.00
173.19
272.74
265.94
226.99
Short Term Loans & Adv.
396.00
462.00
286.00
335.00
352.00
272.00
172.21
272.74
265.94
197.75
Net Current Assets
984.00
423.00
-718.00
-1,521.00
-762.00
-840.00
-1,096.64
-49.01
687.89
2,556.46
Total Assets
8,047.00
7,482.00
6,959.00
6,781.00
7,526.00
7,232.00
7,720.20
7,571.04
7,978.48
8,848.84

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
390.00
-22.00
219.00
153.00
413.00
-287.00
648.96
183.32
68.44
-269.47
PBT
238.00
-16.00
-420.00
-624.00
-411.00
916.00
-196.68
-300.32
-641.15
-247.15
Adjustment
455.00
455.00
677.00
635.00
554.00
-943.00
483.23
444.52
448.78
303.04
Changes in Working Capital
-282.00
-492.00
-8.00
153.00
367.00
-143.00
379.58
80.29
278.33
-297.39
Cash after chg. in Working capital
411.00
-53.00
249.00
164.00
510.00
-170.00
666.13
224.49
85.96
-241.50
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-21.00
31.00
-30.00
-11.00
-97.00
-117.00
-17.17
-41.17
-17.52
-27.97
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-241.00
-783.00
-137.00
-125.00
-201.00
1,470.00
-155.53
94.57
630.24
-686.64
Net Fixed Assets
-383.00
-411.00
-1.00
31.00
-416.00
-200.42
-499.84
-39.00
-45.55
-166.75
Net Investments
10.00
-422.00
0.00
0.00
0.00
0.27
0.00
-0.05
0.00
0.00
Others
132.00
50.00
-136.00
-156.00
215.00
1,670.15
344.31
133.62
675.79
-519.89
Cash from Financing Activity
-54.00
409.00
334.00
-315.00
-71.00
-1,171.00
-679.58
-776.45
-769.47
1,254.49
Net Cash Inflow / Outflow
95.00
-396.00
416.00
-287.00
141.00
12.00
-186.15
-498.56
-70.79
298.38
Opening Cash & Equivalents
112.00
505.00
90.00
370.00
232.00
219.00
397.34
897.24
963.64
662.98
Closing Cash & Equivalent
217.00
112.00
505.00
90.00
370.00
232.00
219.34
397.34
897.24
963.64

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
304.14
268.02
217.27
231.81
266.04
280.48
238.55
238.75
254.47
298.51
ROA
2.53%
-0.78%
-6.67%
-8.42%
-3.71%
-3.93%
-0.57%
-2.79%
-7.93%
-2.69%
ROE
4.29%
-1.48%
-14.12%
-17.32%
-7.77%
-9.92%
-1.64%
-7.94%
-21.81%
-6.42%
ROCE
6.79%
4.07%
-2.15%
-5.88%
-1.96%
-5.50%
1.32%
-0.56%
-5.47%
-0.31%
Fixed Asset Turnover
0.65
0.67
0.63
0.73
0.88
0.75
0.52
0.70
0.70
0.82
Receivable days
58.75
60.36
71.63
73.25
65.29
85.04
138.12
98.15
92.57
97.55
Inventory Days
75.82
64.42
65.71
60.95
55.76
58.60
82.83
73.51
91.03
100.47
Payable days
186.21
218.94
255.81
293.71
232.91
255.87
129.66
86.65
67.29
64.08
Cash Conversion Cycle
-51.64
-94.15
-118.47
-159.51
-111.86
-112.23
91.29
85.01
116.31
133.94
Total Debt/Equity
0.43
0.43
0.63
0.57
0.49
0.70
1.22
1.28
1.33
1.26
Interest Cover
2.12
0.94
-0.38
-1.07
-0.37
-1.28
0.29
-0.13
-1.51
-0.10

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Wockhardt secures USFDA’s approval for ZAYNICH
    1st Jun 2026, 14:30 PM

    ZAYNICH is the first New Chemical Entity fully developed and commercialized by an Indian pharmaceutical company to receive an USFDA approval

    Read More
  • Wockhardt gets CDSCO’s nod to import, market ‘Zaynich’ in India
    28th May 2026, 14:38 PM

    The approval is for the treatment of adult patients (=18 years) with complicated urinary tract infections

    Read More
  • Wockhardt - Quarterly Results
    5th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.